Cargando…
Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
Recent advances in non-small cell lung cancer (NSCLC) biology and the discovery of novel therapeutic targets have led to the development of new pharmacological agents that may improve the clinical outcome of patients with NSCLC. The glucocorticoid receptor (GR) is an evolutionarily conserved protein...
Autores principales: | Papavassiliou, Kostas A., Anagnostopoulos, Nektarios, Papavassiliou, Athanasios G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526876/ https://www.ncbi.nlm.nih.gov/pubmed/37759686 http://dx.doi.org/10.3390/biom13091286 |
Ejemplares similares
-
Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
por: Gargalionis, Antonios N., et al.
Publicado: (2023) -
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
por: Papavassiliou, Kostas A., et al.
Publicado: (2021) -
The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022) -
Lung Cancer through Transcription Factors
por: Papavassiliou, Kostas A., et al.
Publicado: (2023) -
Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?
por: Kassi, Eva N., et al.
Publicado: (2020)